ELBALURAN 20 MG 30 F.C. TABS

ATYPICAL ANTIPSYCHOTIC; PRECISE MECHANISM IS UNKNOWN; EFFICACY SUGGESTED TO INVOLVE MEDIATION OF CENTRAL DOPAMINE TYPE 2 AND SEROTONIN TYPE 2 (5HT-2A) RECEPTOR ANTAGONISM. INDICATED FOR SCHIZOPHRENIA 40 MG PO QDAY INITIALLY; NOT TO EXCEED 160 MG/DAY INDICATED AS MONOTHERAPY FOR ADULTS WITH MAJOR DEPRESSIVE EPISODE ASSOCIATED WITH BIPOLAR I DISORDER (BIPOLAR DEPRESSION) 20 MG PO QDAY INITIALLY; MAY INCREASE DOSE IF NEEDED NOT TO EXCEED 120 MG/DAY. INDICATED AS ADJUNCTIVE THERAPY FOR MAJOR DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR I DISORDER WITH LITHIUM OR VALPROATE 20 MG PO QDAY INITIALLY; MAY INCREASE DOSE IF NEEDED NOT TO EXCEED 120 MG/DAY.